Tribun Health Overview
- Year Founded
-
2016
- Status
-
Private
- Employees
-
40
- Latest Deal Type
-
Series A2
- Latest Deal Amount
-
$17.1M
- Investors
-
8
Tribun Health General Information
Description
Developer of an enterprise digital pathology and artificial intelligence platform designed to support pathology diagnostics workflows. The company offers scalable and interoperable tools for managing, visualizing, analyzing, and sharing pathology data, enabling healthcare organizations, pharmaceutical companies, and research institutions to standardize workflows, improve diagnostic efficiency, and support precision medicine.
Contact Information
Website
www.tribun.healthCorporate Office
- 30 boulevard de Vaugirard
- 75015 Paris
- France
Corporate Office
- 30 boulevard de Vaugirard
- 75015 Paris
- France
Tribun Health Timeline
Tribun Health Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 5. Later Stage VC (Series A2) | 02-Aug-2026 | $17.1M | Completed | Generating Revenue | ||
| 4. Accelerator/Incubator | Completed | Generating Revenue | ||||
| 3. Later Stage VC (Series B) | 01-Dec-2022 | Completed | Generating Revenue | |||
| 2. Accelerator/Incubator | 26-Jun-2020 | $33.7K | $6.8M | Completed | Generating Revenue | |
| 1. Early Stage VC (Series A) | 16-Jul-2019 | $6.77M | $6.77M | Completed | Generating Revenue |
Tribun Health Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series B | ||||||||
| Series B | ||||||||
| Series A | 15,080 | $10.211528 | $406.25 | $406.25 | 1x | $406.25 | 38.7% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
Tribun Health Comparisons
Industry
Financing
Details
Tribun Health Competitors (11)
One of Tribun Health’s 11 competitors is 3DHistech, a Corporation company based in Budapest, Hungary.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| 3DHistech | Corporation | Budapest, Hungary | ||||
| DNAlytics | Formerly Accelerator/Incubator backed | Louvain-la-Neuve, Belgium | ||||
| Leica Biosystems Nussloch | Corporation | Nussloch, Germany | ||||
| FujiFilm | Venture Capital-Backed | Tokyo, Japan | ||||
| Inspirata Digital Pathology Solution (Dynamyx Software) | Corporate Backed or Acquired | Tampa, FL |
Tribun Health Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Tribun Health Patents
Tribun Health Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| FR-3143311-A1 | Method for assisting in the classification of a histological section of a patient, associated device | Pending | 19-Dec-2022 | ||
| US-20260212496-A1 | Method for assisting with the classification of a histological section from a patient, associated device | Pending | 19-Dec-2022 | ||
| WO-2024134083-A1 | Method for assisting with the classification of a histological section of a patient, associated device | Inactive | 19-Dec-2022 | ||
| EP-4511793-A1 | Method for determining a region of interest in an image of a biological sample | Pending | 22-Apr-2022 | ||
| FR-3134911-A1 | Method for determining a region of interest in an image of a biological sample | Active | 22-Apr-2022 | G06V20/695 |
Tribun Health Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Tribun Health Investors (8)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Asclepios Bioresearch | Venture Capital | Minority | ||
| Bpifrance | Sovereign Wealth Fund | Minority | ||
| Owkin | VC-Backed Company | Minority | ||
| Tenax Therapeutics | Corporation | Minority | ||
| Vivalto Sante | PE-Backed Company | Minority |
Tribun Health Acquisitions (1)
Tribun Health’s most recent deal was a Merger/Acquisition with Keen Eye. The deal was made on 01-Jan-2023.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Keen Eye | 01-Jan-2023 | Merger/Acquisition | Discovery Tools (Healthcare) |
Tribun Health FAQs
-
When was Tribun Health founded?
Tribun Health was founded in 2016.
-
Where is Tribun Health headquartered?
Tribun Health is headquartered in Paris, France.
-
What is the size of Tribun Health?
Tribun Health has 40 total employees.
-
What industry is Tribun Health in?
Tribun Health’s primary industry is Diagnostic Equipment.
-
Is Tribun Health a private or public company?
Tribun Health is a Private company.
-
What is Tribun Health’s current revenue?
The current revenue for Tribun Health is .
-
How much funding has Tribun Health raised over time?
Tribun Health has raised $44.4M.
-
Who are Tribun Health’s investors?
Asclepios Bioresearch, Bpifrance, Owkin, Tenax Therapeutics, and Vivalto Sante are 5 of 8 investors who have invested in Tribun Health.
-
Who are Tribun Health’s competitors?
3DHistech, DNAlytics, Leica Biosystems Nussloch, FujiFilm, and Inspirata Digital Pathology Solution (Dynamyx Software) are some of the 11 competitors of Tribun Health.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
